Core Viewpoint - The E'min County Market Supervision Administration is committed to maintaining drug market order and ensuring drug safety through regular and detailed inspections of pharmacies and medical institutions [1][2] Group 1: Regulatory Focus - The administration emphasizes three core areas during inspections of retail pharmacies: compliance with qualifications, operational standards, and quality control [1] - Inspections include verifying the validity of drug operation licenses and ensuring that pharmacists are present and following proper prescription protocols [1] - The storage conditions of drugs are also scrutinized, ensuring that cold storage temperatures meet standards and that drugs are stored according to regulations to prevent quality issues [1] Group 2: Medical Institutions Oversight - The administration focuses on traceability of sources, quality control, and compliance in the procurement and use of drugs and medical devices in medical institutions [1] - Key checks include ensuring that medical institutions purchase drugs and devices from legal channels and do not use expired or unqualified products [1] Group 3: Approach to Regulation - The administration adopts a dual approach of service and regulation, combining education with enforcement, addressing minor issues with on-the-spot guidance and taking legal action against violations [2] - Future plans include maintaining a high-pressure regulatory stance through regular inspections and follow-up checks to reinforce regulatory effectiveness [2]

Core Points - The document provides a public disclosure of the results from the supervision and inspection of medical device operating enterprises in Jing'an District, Shanghai, for June 2025, highlighting compliance and non-compliance outcomes [2][3][4]. Summary by Categories Inspection Results - A total of 100 medical device operating enterprises were inspected, with most passing the checks, indicating a high level of compliance within the industry [2][3]. - Specific companies such as Shanghai Huizhi Feng Medical Device Co., Ltd. and Shanghai Yike New Retail Network Technology Co., Ltd. passed inspections conducted on June 3, 2025 [2]. - Some companies, like Shanghai Anmuning Medical Device Co., Ltd., required corrective actions but passed upon re-inspection [2][3]. Compliance Status - The majority of enterprises received notifications of passing inspections, while a few were noted for needing improvements or further investigation due to compliance issues [3][4]. - Companies like Shanghai Yifeng Pharmacy Chain Co., Ltd. and Shanghai Hufeng Pharmaceutical Co., Ltd. consistently showed compliance across multiple inspections [2][3]. Follow-up Actions - Several enterprises were given deadlines for corrective actions, with some requiring on-site follow-ups to ensure compliance [3][4]. - The document indicates ongoing monitoring and regulatory oversight to maintain industry standards and ensure public safety [2][3].